MANILA, Philippines – An economist belonging to the expert panel that did not recommend the mass use of the controversial dengue vaccine in the Philippines said the budget allotted for it was too much.
Hilton Lam was among the members of the Formulary Executive Council (FEC) who testified during the Senate investigation into the controversy hounding ...
December 11, 2017 at 06:10PM
Post a Comment